Pages that link to "Item:Q4563265"
From MaRDI portal
The following pages link to Incorporating historical information in biosimilar trials: Challenges and a hybrid Bayesian‐frequentist approach (Q4563265):
Displaying 5 items.
- Commensurate priors for incorporating historical information in clinical trials using general and generalized linear models (Q2633931) (← links)
- Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control (Q3299104) (← links)
- Confidence intervals with maximal average power (Q5092716) (← links)
- BOB: Bayesian optimal design for biosimilar trials with co-primary endpoints (Q6629374) (← links)
- Power prior for borrowing the real-world data in bioequivalence test with a parallel design (Q6637078) (← links)